Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-132,666
Closed -$3.35M 1583
2026
Q1
$3.35M Buy
132,666
+72,071
+119% +$1.83M 0.03% 575
2025
Q4
$1.44M Sell
60,595
-113,258
-65% -$2.64M 0.01% 874
2025
Q3
$4.07M Sell
173,853
-6,192
-3% -$149K 0.04% 488
2025
Q2
$3.99M Buy
180,045
+168,032
+1,399% +$3.68M 0.04% 491
2025
Q1
$276K Buy
+12,013
New +$283K ﹤0.01% 1247
2024
Q2
Sell
-92,714
Closed -$3.15M 1533
2024
Q1
$3.15M Buy
+92,714
New +$3.53M 0.02% 543
2023
Q4
Sell
-12,320
Closed -$470K 1482
2023
Q3
$470K Buy
12,320
+5,177
+72% +$217K ﹤0.01% 1265
2023
Q2
$326K Buy
+7,143
New +$333K ﹤0.01% 1505
2022
Q3
Sell
-9,899
Closed -$487K 1880
2022
Q2
$487K Buy
+9,899
New +$531K 0.01% 1373
2020
Q1
Sell
-8,746
Closed -$405K 1089
2019
Q4
$405K Buy
+8,746
New +$419K 0.01% 983

Other funds holding BCE

Michael Gelband's BCE Position: Q2 2026 in Review

Michael Gelband sold out of BCE (BCE) in Q2 2026, closing a stake of 132,666 shares — an estimated $3.35M sold.

Michael Gelband first reported a position in BCE in Q4 2019 and held it in 10 quarters. The position peaked at $4.07M in Q3 2025. 389 funds tracked by Wall St. Rank hold BCE as of Q2 2026.

  • Michael Gelband reported no remaining BCE position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 132,666 BCE shares in Q2 2026, an estimated $3.35M.
  • Michael Gelband first reported a position in BCE in Q4 2019 and held it in 10 quarters.
  • Michael Gelband's BCE position peaked at $4.07M in Q3 2025.
  • 389 funds tracked by Wall St. Rank held BCE as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.